Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 115 entries
View as:

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

Phase: N/A Priority: Normal
NCT ID: NCT06544720 Org: User:
Start: 08/02/23 End: 12/31/26 Due: 12/31/27

Effects of Omega-3 Fish Oil Fat Emulsion on Rehabilitation and Immune Function After Radical Surgery Combined With Intraperitoneal Hyperthermic Infusion Chemotherapy in Patients With Locally Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06047158 Org: User:
Start: 12/01/22 End: 12/01/23 Due: 12/01/24

Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）

Phase: N/A Priority: Normal
NCT ID: NCT03735264 Org: User:
Start: 11/15/18 End: 10/15/20 Due: 10/15/21

Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05539768 Org: User:
Start: 10/08/22 End: 03/31/27 Due: 03/31/28

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT04445922 Org: User:
Start: 07/04/20 End: 10/30/20 Due: 10/30/21

Study for Patients With Lung Metastatic Advanced Gastric Cancer and NSCLC Treated With Apatinib

Phase: N/A Priority: Normal
NCT ID: NCT03629691 Org: User:
Start: 02/01/15 End: 05/19/18 Due: 05/19/19

Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05512416 Org: User:
Start: 08/31/22 End: 05/31/24 Due: 05/31/25

Gastrointestinal Surgery Study Group 2001

Phase: N/A Priority: Normal
NCT ID: NCT04636099 Org: User:
Start: 11/01/20 End: 11/30/23 Due: 11/30/24

Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05584852 Org: User:
Start: 11/01/22 End: 05/01/23 Due: 05/01/24

Bioequivalence of Dotilavir Sodium Tablets in Healthy Subjects in the Fasting and Fed State

Phase: N/A Priority: Normal
NCT ID: NCT05168176 Org: User:
Start: 12/01/21 End: 01/31/22 Due: 01/31/23

SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL With p53 and/or c-Myc Expression

Phase: N/A Priority: Normal
NCT ID: NCT05498636 Org: User:
Start: 10/01/22 End: 12/31/25 Due: 12/31/26

A Study on the Clinical Use of a New Expandable OLIF Cage With Posterior Bone Grafting in Lumbar Spine Surgery

Phase: N/A Priority: Normal
NCT ID: NCT07028099 Org: User:
Start: 06/10/25 End: 05/31/27 Due: 05/31/28

Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)

Phase: N/A Priority: Normal
NCT ID: NCT04713059 Org: User:
Start: 01/01/20 End: 01/01/23 Due: 01/01/24

Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04411875 Org: User:
Start: 11/13/18 End: 02/15/19 Due: 02/15/20

Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05352802 Org: User:
Start: 09/01/22 End: 05/01/27 Due: 05/01/28

Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06916338 Org: User:
Start: 04/11/25 End: 12/31/27 Due: 12/31/28

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06916624 Org: User:
Start: 04/12/25 End: 12/31/26 Due: 12/31/27

A New Modified Suture Bridge Technique

Phase: N/A Priority: Normal
NCT ID: NCT04825249 Org: User:
Start: 12/30/18 End: 01/05/21 Due: 01/05/22

Remote Blood Pressure Management Clinical Application Research

Phase: N/A Priority: Normal
NCT ID: NCT04690478 Org: User:
Start: 06/01/20 End: 06/30/23 Due: 06/30/24

The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04782622 Org: User:
Start: 03/01/21 End: 03/01/23 Due: 03/01/24

Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04885660 Org: User:
Start: 10/12/18 End: 11/20/19 Due: 11/20/20

SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI)

Phase: N/A Priority: Normal
NCT ID: NCT05012540 Org: User:
Start: 08/01/13 End: 12/31/20 Due: 12/31/21

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

Phase: N/A Priority: Normal
NCT ID: NCT05297968 Org: User:
Start: 05/13/21 End: 06/27/21 Due: 06/27/22

Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

Phase: N/A Priority: Normal
NCT ID: NCT06066112 Org: User:
Start: 09/20/23 End: 03/31/24 Due: 03/31/25

Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05976737 Org: User:
Start: 08/17/23 End: 07/12/24 Due: 07/12/25